Condition
B Lymphoblastic Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 B Lymphoblastic Lymphoma clinical trials that are recruiting, at sites in 6 countries (most in United States (3), Australia (1), Canada (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 6Countries
Newest B Lymphoblastic Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Lower versus higher hemoglobin thresholds for red blood cell transfusions in adults with high-grade myeloid cancers or B-cell ALL/lymphoma | — | Seattle, Washington | Recruiting | Nov 29, 2024 |
| CAR T cell therapy for children with relapsed B-cell leukemia | — | Tianjin, Tianjin Municipality and 1 other locations | Recruiting | Apr 9, 2024 |
| Using inotuzumab ozogamicin with chemotherapy for high-risk B-cell leukemia | Phase 3 | Birmingham, Alabama and 230 other locations | Recruiting | May 22, 2019 |
| Using blinatumomab, inotuzumab ozogamicin, and chemotherapy to treat B acute lymphoblastic leukemia | Phase 2 | Houston, Texas | Recruiting | Aug 24, 2016 |
All recruiting trials (4)
-
Lower versus higher hemoglobin thresholds for red blood cell transfusions in adults with high-grade myeloid cancers or B-cell ALL/lymphoma
This will see if giving transfusions only when hemoglobin drops to 7 g/dL instead of 9 g/dL affects quality of life and physical functioning for adults receiving intensive chemotherapy or allogeneic stem cell transplant for high-grade myeloid cancers or B-cell ALL/lymphoma.
-
CAR T cell therapy for children with relapsed B-cell leukemia
This study is testing a new CAR T cell therapy to see if it can help children aged 3 to 18 with relapsed or hard-to-treat B-cell leukemia.
-
Using inotuzumab ozogamicin with chemotherapy for high-risk B-cell leukemia
This study is testing if adding a targeted therapy called inotuzumab ozogamicin to standard chemotherapy can help young patients with high-risk B-cell leukemia live longer without their cancer coming back.
-
Using blinatumomab, inotuzumab ozogamicin, and chemotherapy to treat B acute lymphoblastic leukemia
This study is testing a new combination of two immunotherapy drugs and chemotherapy to see if it helps people with newly diagnosed B acute lymphoblastic leukemia live longer and stay cancer-free.
Related topics
Quick answers
How many B Lymphoblastic Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), Australia (1 trial), Canada (1 trial), New Zealand (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.